Dysautonomia Intl. on X: Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well to the medication. Read

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. on X: Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well to the medication. Read

WTJD effect on depression rats with kidney yang deficiency

Diagnostics and Management of Dysautonomia in Childhood

POTS (Postural Orthostatic Tachycardia Syndrome) and Dysautonomia In ME/CFS, FM, and Long COVID

Pharmacologic Intervention

Solved State whether the investigation in question is an

Dysautonomia Intl. (@Dysautonomia) / X